26-Jul-2024
Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024
Globe Newswire (Wed, 24-Jul 4:05 PM ET)
Assertio shareholder calls for four board members to resign
Seeking Alpha News (Wed, 24-Jul 1:12 PM ET)
Assertio shareholders calls for four board members to resign
Seeking Alpha News (Wed, 24-Jul 1:12 PM ET)
Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc.
Business Wire (Wed, 24-Jul 9:00 AM ET)
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Globe Newswire (Tue, 9-Jul 4:30 PM ET)
Globe Newswire (Wed, 3-Jul 10:00 PM ET)
Assertio to Participate in the Sidoti Small Cap Conference on June 12, 2024
Globe Newswire (Wed, 5-Jun 8:30 AM ET)
Assertio Announces the Appointment of Brendan P. O'Grady as New CEO
Globe Newswire (Wed, 29-May 7:00 AM ET)
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
Globe Newswire (Fri, 17-May 9:15 AM ET)
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Assertio Holdings trades on the NASDAQ stock market under the symbol ASRT.
As of July 26, 2024, ASRT stock price climbed to $1.50 with 1,568,432 million shares trading.
ASRT has a beta of 2.08, meaning it tends to be more sensitive to market movements. ASRT has a correlation of 0.05 to the broad based SPY ETF.
ASRT has a market cap of $143.16 million. This is considered a Micro Cap stock.
Last quarter Assertio Holdings reported $32 million in Revenue and $.04 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.07.
In the last 3 years, ASRT stock traded as high as $8.01 and as low as $.73.
The top ETF exchange traded funds that ASRT belongs to (by Net Assets): VTI, VXF, PRFZ, BSVO, FDM.
ASRT has underperformed the market in the last year with a price return of -72.6% while the SPY ETF gained +21.0%. However, in the short term, ASRT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +81.7% vs +7.5% return in SPY. But in the last 2 weeks, ASRT shares have been beat by the market, returning -9.3% compared to an SPY return of -2.8%.
ASRT support price is $1.37 and resistance is $1.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASRT stock will trade within this expected range on the day.